Maxim Group Reinstates Buy on Filana Therapeutics, Announces $5 Price Target
Filana Therapeutics Inc FLNA
$1.52
βΌ -1.94%
($-0.03)
Open
$1.56
Prev Close
$1.55
Day Range
$1.48 β $1.56
52W Range
$1.16 β $2.27
Market Cap
$74.88M
Beta
1.07
EPS (TTM)
$-1.61
π Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2000-07-14 |
| Shares Out. | 48,310,000 |
| Website | cassavasciences.com/ β |
| Phone | 13026587581 |
Filana Therapeutics Inc is a publicly traded company under the ticker symbol FLNA on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
π Analyst Ratings
7 analysts (2026-03-01)
